BioTime (BTX) Announces Third Quarter 2012 Financial Results and Recent Corporate Accomplishments  
11/12/2012 9:14:22 AM

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the third quarter and year-to-date period ended September 30, 2012 and highlighted recent corporate accomplishments.